Find contact details for our offices and locations worldwide

General Enquiries

Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR

Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761

Business Development

Hikma Pharmaceuticals LLC
King Abdullah II street
Building 357
P.O. Box 182400
11118 Amman
Jordan

Tel: +962 (6)580 2960
Fax: +962 6 5802962
Email: customers@hikma.com

Investor Relations

Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR

Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: investors@hikma.uk.com

Sales and Marketing

Hikma Pharmaceuticals LLC
King Abdullah II Street
Building 357
P.O. Box 182400
11118 Amman
Jordan

Tel: +962 (6)580 2960
Fax: +962 6 5802962
Email: customers@hikma.com

Sustainability

Hikma Pharmaceuticals LLC
21 Saleem Bin Hareth Street
Industrial Area
Bayader Wadi El-Seer
P.O. Box 182400
11118 Amman
Jordan

Tel: +962 (6)580 2900
Fax: +962 6 5817102
Email: mediainquiries@hikma.com

Media

Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR

Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: mediainquiries@hikma.com

Careers

Hikma Pharmaceuticals LLC
21 Saleem Bin Hareth Street
Industrial Area
Bayader Wadi El-Seer
P.O. Box 182400
11118 Amman
Jordan

Tel: +962 (6) 580 2900
Fax: +962 6 5817102
Email: vacancy@hikma.com

Pharmacovigilance

For Medical Information Enquiries, Complaints and Adverse Drug Experiences please contact:

If you are in the US, and you want to report an event that occurred with a Hikma or West-Ward product, please contact:
us.hikma@primevigilance.com or please call 1.877.845.0689 or 1.800.962.8364.

If you are in Europe, please contact:
portugaleupharmacovigilance@hikma.com

For all other enquires or to report adverse reaction which occurred outside Europe or the United States of America please contact
pharmacovigilance@hikma.com

Careers

Could you support one of our teams? See the opportunities we have to offer.

Shareholder information

Everything you need to manage your shares, including share listings, depositary receipts, share price information, and dividends.

Please note: if you have a question about a medical condition, you should speak to a healthcare professional.